(R)-(-)-3-羟基四氢呋喃
(R)-(-)-3-羟基四氢呋喃结构式
|
常用名 | (R)-(-)-3-羟基四氢呋喃 | 英文名 | 3-Hydroxytetrahydrofuran |
|---|---|---|---|---|
| CAS号 | 86087-24-3 | 分子量 | 88.105 | |
| 密度 | 1.1±0.1 g/cm3 | 沸点 | 181.0±8.0 °C at 760 mmHg | |
| 分子式 | C4H8O2 | 熔点 | N/A | |
| MSDS | 中文版 美版 | 闪点 | 81.1±0.0 °C | |
| 符号 |
GHS07 |
信号词 | Warning |
|
Synthesis of empagliflozin, a novel and selective sodium-glucose co-transporter-2 inhibitor, labeled with carbon-14 and carbon-13.
J. Labelled Comp. Radiopharm. 57(12) , 687-94, (2014) Empagliflozin, (2S,3R,4R,5S,6R)-2-[4-chloro-3-[[4-[(3S)-oxolan-3-yl]oxyphenyl]methyl]phenyl]-6-(hydroxymethyl)oxane-3,4,5-triol was recently approved by the FDA for the treatment of chronic type 2 diabetes mellitus. Herein, we report the synthesis of carbon-1... |
期刊文献综述：
更多...